Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Jefferam1on Dec 14, 2017 9:28am
124 Views
Post# 27154698

RE:RE:RE:Strange market

RE:RE:RE:Strange market
Jefferam1
 - (9/29/2017 12:07:18 PM) 
RE:RE:Strange market
I agree with StrikingMoose statement.
I expect Oct 0.09-0.11, Nov 0.10 - 0.12, Dec 0.12-0.15+
Jan 0.15+ and possibly up to 0.75 - cha ching!

However on that note, I would not be surprised nor would I rush off if I seen the following:
Oct 0.08-0.10, Nov 0.08-0.12, Dec 0.10-0.15
Basically what I'm saying, if we see 0.08 in Sept, Oct and Nov, I won't be surprised. 
I'll be surpsied if we see 0.08 in Dec. 

I don't think we will ever see 0.075 but I will not rule that out and it will not scare me if we do see it in the next 2 months. (Buying oportunity).

No panic till mid Dec. If we see 0.075 on Dec 15, Then I'll start to panic.


Well, we haven't seen 0.075 mid Dec yet, so I'm still not panicking.
Bullboard Posts